5:07 PM
 | 
Apr 12, 2012
 |  BC Extra  |  Top Story

Shire to acquire Pervasis' vascular assets

Shire plc (LSE:SHP; NASDAQ:SHPGY) will acquire the vascular assets of Pervasis Therapeutics Inc. (Cambridge, Mass.) in a deal valued at up to $200 million, including an undisclosed upfront payment and milestones. The deal includes Vascugel,...

Read the full 167 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >